DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System reduced its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 208,705 shares of the medical instruments supplier’s stock after selling 14,489 shares during the quarter. New York State Teachers Retirement System owned about 0.10% of DENTSPLY SIRONA worth $7,428,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in XRAY. MetLife Investment Management LLC raised its stake in DENTSPLY SIRONA by 23.1% in the 1st quarter. MetLife Investment Management LLC now owns 59,453 shares of the medical instruments supplier’s stock valued at $2,926,000 after purchasing an additional 11,156 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in DENTSPLY SIRONA by 6.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,250 shares of the medical instruments supplier’s stock valued at $1,440,000 after buying an additional 1,811 shares in the last quarter. Raymond James Trust N.A. grew its holdings in DENTSPLY SIRONA by 61.7% in the 1st quarter. Raymond James Trust N.A. now owns 7,042 shares of the medical instruments supplier’s stock valued at $346,000 after buying an additional 2,687 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in DENTSPLY SIRONA by 6.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock valued at $90,243,000 after buying an additional 117,571 shares in the last quarter. Finally, Sei Investments Co. grew its holdings in DENTSPLY SIRONA by 18.9% in the 1st quarter. Sei Investments Co. now owns 468,759 shares of the medical instruments supplier’s stock valued at $23,090,000 after buying an additional 74,629 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

XRAY opened at $32.02 on Friday. The stock’s 50-day moving average price is $33.14 and its 200 day moving average price is $32.99. DENTSPLY SIRONA Inc. has a 12-month low of $26.27 and a 12-month high of $43.24. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. The firm had revenue of $1.01 billion for the quarter, compared to analyst estimates of $972.61 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. DENTSPLY SIRONA’s revenue was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.46 EPS. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 12th. Shareholders of record on Friday, March 29th will be given a $0.16 dividend. The ex-dividend date is Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.00%. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -103.22%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on XRAY. Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Barrington Research restated an “outperform” rating and issued a $41.00 target price on shares of DENTSPLY SIRONA in a report on Friday, March 1st. Piper Sandler increased their price target on DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a report on Friday, January 12th. SVB Leerink assumed coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an “outperform” rating and a $42.00 price target for the company. Finally, StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $39.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.